Ectonucleotidase expression on T-helper cells as a response assessment tool to immune-checkpoint therapy in head and neck cancers

Ectonucleotidase expression on T-helper cells as a response assessment tool to immune-checkpoint therapy in head and neck cancers

Saved in:

Bibliographic Details
Main Authors:	B. Arvind, Praneetha Puvvula, Shalini Thakur, Anand Subash, VishalUS. Rao
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024002474
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Examined lymph node count for accurate nodal staging and prognostication in oral tongue squamous cell carcinoma: Specifying the determining factors
by: Parvathy Reghunadhan, et al.
Published: (2024-03-01)

Depth of Resection as a Predictor of LoTTS: Points to Ponder
by: Shaurya Verma, et al.
Published: (2024-03-01)

Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
by: Chrystal Paulos, et al.
Published: (2023-01-01)

Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
by: Zhongxiao Fu, et al.
Published: (2025-01-01)

Skip metastasis in early oral cancer – Extent of nodal clearance
by: Shaurya Verma, et al.
Published: (2024-03-01)

Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma
by: Jeffrey Hiken, et al.
Published: (2025-01-01)

An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
by: Vinod K. Ramani, et al.
Published: (2025-01-01)

T helper cell polarisation as a measure of the maturation of the immune response
by: Scott B. Cameron, et al.
Published: (2003-01-01)

Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance
by: Tiziana Larussa, et al.
Published: (2015-01-01)

Textbook of Head and Neck Anatomy /
by: Hiatt, James L., 1934-
Published: (2002)

Head and Neck Reconstruction in India
by: Prabha Yadav
Published: (2024-12-01)

Virotherapy in Head and Neck Cancer
by: Zhan Wang
Published: (2024-03-01)

Screening of head neck cancer
by: Shrikant B. Mali
Published: (2024-03-01)

Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
by: Nasrin Rastegarvand, et al.
Published: (2022-01-01)

Multi‐omics analysis of pyroptosis‐related genes for prognosis and immune landscape in head and neck cancer
by: Shikang Zheng, et al.
Published: (2024-12-01)

Prognostic Factors of Liposarcoma in Head and Neck
by: Shuo DING, et al.
Published: (2025-01-01)

Evaluation of Head and Neck Lymphadenopathies in Childhood
by: Elif Sinem Yazıcı, et al.
Published: (2024-01-01)

Unleashing immunity against oral cancer with immune checkpoint inhibitors
by: Ajay Guru
Published: (2024-06-01)

Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
by: Eileen S. Kim, et al.
Published: (2016-01-01)

Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01)

The Influence of Neck Muscle Activation on Head and Neck Injuries of Occupants in Frontal Impacts
by: Fan Li, et al.
Published: (2018-01-01)

A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

Microbial signatures in head and neck squamous cell carcinoma: an in silico study
by: Loganathan KAVITHA, et al.
Published: (2025-02-01)

Diseases of the Nose, Throat, Ear, Head, and Neck /
by: Ballenger, John Jacob
Published: (1991)

Genome Stability Pathways in Head and Neck Cancers
by: Glenn Jenkins, et al.
Published: (2013-01-01)

Editorial: The role of the microbiome in head and neck cancer
by: Fabio Cumbo, et al.
Published: (2025-01-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01)

Contemporary Issues in Head and Neck Pathology and Radiology
by: Paul C. Edwards, et al.
Published: (2010-01-01)

Clinical-histopathological concordance in head and neck lesions.
by: Sahily Espino Otero, et al.
Published: (2009-03-01)

Remote head, face and neck pathology and radiology
by: Sayem Anwarhussain Mulla, et al.
Published: (2024-06-01)

Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01)

Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics
by: Ziyang Ye, et al.
Published: (2024-11-01)

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
by: Chunli Huang, et al.
Published: (2022-01-01)

Seven Immune-Related Genes’ Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma
by: Rui Mu, et al.
Published: (2023-01-01)

T follicular helper cells and IgE
by: Yusei Ohshima
Published: (2025-01-01)

Role of Toll-Like Receptor 2 in Regulation of T-Helper Immune Response in Chronic Obstructive Pulmonary Disease
by: Karolina A. Sidletskaya, et al.
Published: (2021-01-01)

Resistance mechanisms to immune checkpoint inhibitors: updated insights
by: Besan H. Alsaafeen, et al.
Published: (2025-01-01)

A review of neurological complications of immune-checkpoint inhibitors
by: D. Valančius, et al.
Published: (2021-12-01)

Identifying factors for pembrolizumab eligibility in head and neck cancer
by: Satoru Miyamaru, et al.
Published: (2025-02-01)